BIONECURE
- Biotech or pharma, therapeutic R&D
A clinical-stage biotech company dedicated developing innovative antibody-drug conjugates (ADCs) for cancer treatment. The company has developed proprietary payload platforms and a diversified pipeline that includes bispecific dual-targeting ADCs and ADCs targeting immune-oncology (IO) targets. The company is seeking partnership and co-development opportunities for its ADC products
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}